Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status
暂无分享,去创建一个
A. Tamiya | S. Atagi | Y. Inagaki | S. Kouno | Y. Taniguchi | Y. Adachi | T. Enomoto | K. Azuma | N. Saijo | K. Okishio